Recent advances in genetic engineering tools based on synthetic biology
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ren, Jun | - |
dc.contributor.author | Lee, Jingyu | - |
dc.contributor.author | Na, Dokyun | - |
dc.date.available | 2020-04-10T03:21:06Z | - |
dc.date.issued | 2020-01 | - |
dc.identifier.issn | 1225-8873 | - |
dc.identifier.issn | 1976-3794 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/38231 | - |
dc.description.abstract | Genome-scale engineering is a crucial methodology to rationally regulate microbiological system operations, leading to expected biological behaviors or enhanced bioproduct yields. Over the past decade, innovative genome modification technologies have been developed for effectively regulating and manipulating genes at the genome level. Here, we discuss the current genome-scale engineering technologies used for microbial engineering. Recently developed strategies, such as clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9, multiplex automated genome engineering (MAGE), promoter engineering, CRISPR-based regulations, and synthetic small regulatory RNA (sRNA)-based knockdown, are considered as powerful tools for genome-scale engineering in microbiological systems. MAGE, which modifies specific nucleotides of the genome sequence, is utilized as a genome-editing tool. Contrastingly, synthetic sRNA, CRISPRi, and CRISPRa are mainly used to regulate gene expression without modifying the genome sequence. This review introduces the recent genome-scale editing and regulating technologies and their applications in metabolic engineering. © 2020, The Microbiological Society of Korea. | - |
dc.format.extent | 10 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Microbiological Society of Korea | - |
dc.title | Recent advances in genetic engineering tools based on synthetic biology | - |
dc.type | Article | - |
dc.identifier.doi | 10.1007/s12275-020-9334-x | - |
dc.identifier.bibliographicCitation | Journal of Microbiology, v.58, no.1, pp 1 - 10 | - |
dc.identifier.kciid | ART002537863 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000511694400001 | - |
dc.identifier.scopusid | 2-s2.0-85077202859 | - |
dc.citation.endPage | 10 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 1 | - |
dc.citation.title | Journal of Microbiology | - |
dc.citation.volume | 58 | - |
dc.type.docType | Review | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | CRISPR | - |
dc.subject.keywordAuthor | CRISPRa | - |
dc.subject.keywordAuthor | CRISPRi | - |
dc.subject.keywordAuthor | genome-scale engineering | - |
dc.subject.keywordAuthor | MAGE | - |
dc.subject.keywordAuthor | metabolic engineering | - |
dc.subject.keywordAuthor | promoter engineering | - |
dc.subject.keywordAuthor | synthetic sRNA | - |
dc.subject.keywordPlus | RIBOSOME BINDING-SITES | - |
dc.subject.keywordPlus | SMALL RNA REGULATORS | - |
dc.subject.keywordPlus | ESCHERICHIA-COLI | - |
dc.subject.keywordPlus | CONSTITUTIVE PROMOTERS | - |
dc.subject.keywordPlus | POTENTIAL TOOL | - |
dc.subject.keywordPlus | IN-VIVO | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | OVEREXPRESSION | - |
dc.subject.keywordPlus | RECOMBINATION | - |
dc.subject.keywordPlus | TRANSCRIPTION | - |
dc.relation.journalResearchArea | Microbiology | - |
dc.relation.journalWebOfScienceCategory | Microbiology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.